drugset / Trial / NCT04259112

Effect of Pneumoperitoneum and Neuromuscular Block on Renal Function in Diabetes Patients

NCT04259112

RandomizedFactorialTriple-blindTreatment

Summary

In this single center, double-blind, randomized controlled clinical trial, we will include 648 diabetes patients aged 18-70 undergoing laparoscopic pelvic tumor resection. They will be randomized to the following four groups: high-pressure pneumoperitoneum (10mmHg)+ deep neuromuscular block group, high-pressure pneumoperitoneum (15mmHg)+moderate neuromuscular block group, low-pressure pneumoperitoneum + deep neuromuscular block group and low-pressure pneumoperitoneum+moderate neuromuscular block group. Deep neuromuscular block is defined as post tetanic count (PTC) 1-2, and low neuromuscular block is defined as train-of-four (TOF) twitch 1-2. The outcomes will be indicators for acute kidney injury and surgical condition.

Timeline

Start
2020-10-01
Primary completion
2023-10-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rocuronium Other / unclassified 0.3 mg/kg
Subject Rocuronium Other / unclassified 0.6 mg/kg